IT1303683B1 - PHARMACEUTICAL COMPOSITION WITH ANTI-TUMORAL ACTION CONTAINING DNACODIFIER FOR FRAGMENTS OF AN ANTIGENIC PROTEIN. - Google Patents

PHARMACEUTICAL COMPOSITION WITH ANTI-TUMORAL ACTION CONTAINING DNACODIFIER FOR FRAGMENTS OF AN ANTIGENIC PROTEIN.

Info

Publication number
IT1303683B1
IT1303683B1 IT1998MI002330A ITMI982330A IT1303683B1 IT 1303683 B1 IT1303683 B1 IT 1303683B1 IT 1998MI002330 A IT1998MI002330 A IT 1998MI002330A IT MI982330 A ITMI982330 A IT MI982330A IT 1303683 B1 IT1303683 B1 IT 1303683B1
Authority
IT
Italy
Prior art keywords
dnacodifier
fragments
pharmaceutical composition
antigenic protein
action containing
Prior art date
Application number
IT1998MI002330A
Other languages
Italian (it)
Inventor
Dino Parente
MASSIMO Anna Maria DI
Santis Rita De
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of ITMI982330A0 publication Critical patent/ITMI982330A0/en
Priority to IT1998MI002330A priority Critical patent/IT1303683B1/en
Priority to EP99971329A priority patent/EP1124956A2/en
Priority to MXPA01004186A priority patent/MXPA01004186A/en
Priority to CZ20011521A priority patent/CZ20011521A3/en
Priority to HU0103784A priority patent/HUP0103784A2/en
Priority to EA200100395A priority patent/EA200100395A1/en
Priority to PL99348156A priority patent/PL348156A1/en
Priority to AU11522/00A priority patent/AU1152200A/en
Priority to JP2000579265A priority patent/JP2002528519A/en
Priority to PCT/EP1999/007874 priority patent/WO2000025827A2/en
Priority to CA002348745A priority patent/CA2348745A1/en
Priority to CN99812745A priority patent/CN1324406A/en
Priority to BR9914892-7A priority patent/BR9914892A/en
Priority to TR2001/01141T priority patent/TR200101141T2/en
Priority to SK571-2001A priority patent/SK5712001A3/en
Priority to ARP990105316A priority patent/AR020927A1/en
Priority to PE1999001068A priority patent/PE20001287A1/en
Priority to CO99068636A priority patent/CO5231134A1/en
Publication of ITMI982330A1 publication Critical patent/ITMI982330A1/en
Application granted granted Critical
Publication of IT1303683B1 publication Critical patent/IT1303683B1/en
Priority to BG105458A priority patent/BG105458A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001136—Cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT1998MI002330A 1998-10-30 1998-10-30 PHARMACEUTICAL COMPOSITION WITH ANTI-TUMORAL ACTION CONTAINING DNACODIFIER FOR FRAGMENTS OF AN ANTIGENIC PROTEIN. IT1303683B1 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT1998MI002330A IT1303683B1 (en) 1998-10-30 1998-10-30 PHARMACEUTICAL COMPOSITION WITH ANTI-TUMORAL ACTION CONTAINING DNACODIFIER FOR FRAGMENTS OF AN ANTIGENIC PROTEIN.
CA002348745A CA2348745A1 (en) 1998-10-30 1999-10-18 Dna molecules encoding muc-1 and use thereof in tumor vaccination
BR9914892-7A BR9914892A (en) 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of a DNA encoding antigenic protein with antitumor effect
CZ20011521A CZ20011521A3 (en) 1998-10-30 1999-10-18 Pharmaceutical preparation containing DNA fragments encoding antigenic protein exhibiting antitumor activity
HU0103784A HUP0103784A2 (en) 1998-10-30 1999-10-18 Dna molecules encoding muc-1 and use thereof in tumor vaccination
EA200100395A EA200100395A1 (en) 1998-10-30 1999-10-18 PHARMACEUTICAL COMPOSITION CONTAINING DNA FRAGMENTS ENCODING ANTIGENIC PROTEIN COATING ANTI-ANTITROTHAL EFFECT
PL99348156A PL348156A1 (en) 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect
AU11522/00A AU1152200A (en) 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect
JP2000579265A JP2002528519A (en) 1998-10-30 1999-10-18 Pharmaceutical composition containing DNA encoding an antigenic protein having antitumor effect
PCT/EP1999/007874 WO2000025827A2 (en) 1998-10-30 1999-10-18 Dna molecules encoding muc-1 and use thereof in tumor vaccination
EP99971329A EP1124956A2 (en) 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect
CN99812745A CN1324406A (en) 1998-10-30 1999-10-18 DNA molecules encoding MUC-1 and use thereof in tumor vaccination
MXPA01004186A MXPA01004186A (en) 1998-10-30 1999-10-18 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect.
TR2001/01141T TR200101141T2 (en) 1998-10-30 1999-10-18 Pharmaceutical composition containing fragments of a DNA encoding antigenic protein with antitumor effect
SK571-2001A SK5712001A3 (en) 1998-10-30 1999-10-18 Pharmaceutical composition
ARP990105316A AR020927A1 (en) 1998-10-30 1999-10-21 PHARMACEUTICAL COMPOSITION CONTAINING CODING DNA FRAGMENTS OF AN ANTIGEN PROTEIN GIVEN WITH ANTITUMORAL EFFECT
PE1999001068A PE20001287A1 (en) 1998-10-30 1999-10-22 PHARMACEUTICAL COMPOSITION CONTAINING DNA FRAGMENTS ENCODING AN ANTIGENIC PROTEIN WITH ANTITUMORAL EFFECT
CO99068636A CO5231134A1 (en) 1998-10-30 1999-10-29 PHARMACEUTICAL COMPOSITION CONTAINING FRAGMENTS OF CODING DNA OF AN ANTIGEN PROTEIN WITH ANTITUMORAL EFFECT
BG105458A BG105458A (en) 1998-10-30 2001-04-20 Dna molecules encoding muc-1 and use thereof in tumor vaccination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002330A IT1303683B1 (en) 1998-10-30 1998-10-30 PHARMACEUTICAL COMPOSITION WITH ANTI-TUMORAL ACTION CONTAINING DNACODIFIER FOR FRAGMENTS OF AN ANTIGENIC PROTEIN.

Publications (3)

Publication Number Publication Date
ITMI982330A0 ITMI982330A0 (en) 1998-10-30
ITMI982330A1 ITMI982330A1 (en) 2000-04-30
IT1303683B1 true IT1303683B1 (en) 2001-02-23

Family

ID=11380969

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI002330A IT1303683B1 (en) 1998-10-30 1998-10-30 PHARMACEUTICAL COMPOSITION WITH ANTI-TUMORAL ACTION CONTAINING DNACODIFIER FOR FRAGMENTS OF AN ANTIGENIC PROTEIN.

Country Status (19)

Country Link
EP (1) EP1124956A2 (en)
JP (1) JP2002528519A (en)
CN (1) CN1324406A (en)
AR (1) AR020927A1 (en)
AU (1) AU1152200A (en)
BG (1) BG105458A (en)
BR (1) BR9914892A (en)
CA (1) CA2348745A1 (en)
CO (1) CO5231134A1 (en)
CZ (1) CZ20011521A3 (en)
EA (1) EA200100395A1 (en)
HU (1) HUP0103784A2 (en)
IT (1) IT1303683B1 (en)
MX (1) MXPA01004186A (en)
PE (1) PE20001287A1 (en)
PL (1) PL348156A1 (en)
SK (1) SK5712001A3 (en)
TR (1) TR200101141T2 (en)
WO (1) WO2000025827A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
WO2001057068A1 (en) * 2000-02-01 2001-08-09 The Austin Research Institute Mucin-1 derived antigens and their use in immunotherapy
KR20030068536A (en) * 2000-09-11 2003-08-21 다나-파버 캔서 인스티튜트 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
EP1531842A4 (en) 2000-12-22 2007-03-07 Dana Farber Cancer Inst Inc Regulation of cell growth by muc1
RU2343195C2 (en) * 2003-03-24 2009-01-10 Дзе Скриппс Рисерч Инститьют Dna-vaccine against tumoral growth and ways of their application
US7696306B2 (en) 2003-07-11 2010-04-13 Board of Agents of the University of Nebraska Compositions and methods for preventing or treating cancer
WO2005042573A1 (en) * 2003-10-24 2005-05-12 Dana-Farber Cancer Institute, Inc. Modulation of the interaction of muc1 with muc1 ligands
US7871784B2 (en) 2007-02-02 2011-01-18 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins
WO2008097840A2 (en) 2007-02-02 2008-08-14 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of muc1 by hsf1 and stat3
CN106279435B (en) * 2016-08-16 2019-06-07 新乡医学院 Target anti-tumor vaccine, encoding gene, expression vector, expression engineering bacteria and the application of VEGF and mucin1
CN114230655A (en) * 2021-03-24 2022-03-25 深圳市新靶向生物科技有限公司 Antigenic peptide combination related to esophageal cancer driver gene mutation and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262545B (en) * 1993-10-25 1996-07-02 Menarini Ricerche Sud S P A A EXPRESSION SYSTEM FOR EUKARYOTIC CELL LINES
CA2282300C (en) * 1997-02-24 2011-08-02 Therion Biologics Corporation Recombinant pox virus for immunization against muc1 tumor-associated antigen

Also Published As

Publication number Publication date
JP2002528519A (en) 2002-09-03
HUP0103784A2 (en) 2002-02-28
ITMI982330A1 (en) 2000-04-30
WO2000025827A2 (en) 2000-05-11
CN1324406A (en) 2001-11-28
ITMI982330A0 (en) 1998-10-30
CA2348745A1 (en) 2000-05-11
SK5712001A3 (en) 2002-04-04
AR020927A1 (en) 2002-06-05
MXPA01004186A (en) 2002-06-04
CO5231134A1 (en) 2002-12-27
BR9914892A (en) 2001-07-17
PE20001287A1 (en) 2000-12-07
TR200101141T2 (en) 2001-09-21
CZ20011521A3 (en) 2001-10-17
BG105458A (en) 2002-06-28
EA200100395A1 (en) 2001-10-22
EP1124956A2 (en) 2001-08-22
PL348156A1 (en) 2002-05-06
AU1152200A (en) 2000-05-22
WO2000025827A3 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
TR199901077A2 (en) �spen�iyari form�lasyonlar.
DK1001813T3 (en) Pharmaceutical formulations containing voriconazole
ID27415A (en) PHARMACEUTICAL COMPOSITION
PT875252E (en) PROTEIN FORMULATIONS C ACTIVATED
PT981375E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PLASMA PROTEINS
FI991485A (en) New pharmaceutical composition
DK1524266T3 (en) Pharmaceutical composition
NO20015175L (en) Pharmaceutical composition
NL1015859A1 (en) Pharmaceutical preparations.
CY2006006I1 (en) PROTEIN FORMULATIONS
FR2775596B1 (en) NEW PHARMACEUTICAL COMPOSITIONS
BR9909831B1 (en) dental composition of two components.
ID29262A (en) PHARMACEUTICAL COMPOSITION
EE05020B1 (en) The pharmaceutical composition of G1buride
PT988861E (en) STABILIZED PROTEIN FORMULATIONS
NO20015670L (en) Improved pharmaceutical formulations
IT1303683B1 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-TUMORAL ACTION CONTAINING DNACODIFIER FOR FRAGMENTS OF AN ANTIGENIC PROTEIN.
ID27201A (en) PHARMACEUTICAL COMPOSITION
ITMI982222A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENERPHINE
DK1077681T3 (en) Levothyroxine sodium-containing pharmaceutical composition
ID27150A (en) PHARMACEUTICAL MATERIALS LEVOTIROXIDE
ITMI20011637A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING CITALOPRAM
DE69926012D1 (en) PHARMACEUTICAL PREPARATIONS
IT1304423B1 (en) METHOD OF FEEDING CIGARETTES TO ONE MOUTH OUTLET.
FR2779145B1 (en) NEW PHARMACEUTICAL COMPOSITIONS